.OS Therapies will certainly list on the NYSE American stock exchange this morning by means of a $6....
.ALX Oncology's stage 2 gastric cancer cells response fee has compromised. After seeing its CD47 blo...
.Yet Another of Ionis Pharmaceuticals' essential midphase readouts has fallen short of expectations,...
.While Biogen's pharma peers are searching for late-stage resources along with little bit of threat,...
.Instil Bio has been a biotech looking for a pipe after it scrapped its lead assets over the last co...
.Biogen has returned liberties to a very early Alzheimer's disease course to Denali Therapeutics, le...
.Invite to this week's Chutes & Ladders, our summary of notable management hirings, shootings and...
.Vertex's attempt to handle a rare genetic disease has actually struck another drawback. The biotech...
.Vir Biotechnology's second-quarter incomes record had not been except significant headlines. The pr...
.Galapagos has actually stopped briefly enrollment in a trial of a BCMA-directed CAR-T cell treatmen...